E Scott Priestley

12PUBLICATIONS
26CO-AUTHORS
Biomedical instrumentationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical devicesElectrochemical energy storage and conversionHealth and ecological risk assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 17, 2026
Solubility-Driven Lead Optimization of PAR4 Antagonists and Evaluation of a Phosphate Ester Prodrug Delivery Strategy.

|Aug 22, 2025
Discovery of a Novel Series of iso-Indolinone-Based Glutarimides as Highly Efficacious and Selective IKZF2 Molecular Glue Degraders.

Xuqing Zhang, Harshil Dhruv, Qiaolin Deng

|May 14, 2025
Discovery and Characterization of PVTX-321 as a Potent and Orally Bioavailable Estrogen Receptor Degrader for ER+/HER2- Breast Cancer.

Guozhang Xu, Courtney G Havens, Qiaolin Deng

|May 01, 2025
Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy.

Zhixiang Chen, Harshil Dhruv, Xuqing Zhang

|Apr 08, 2025
Correction to "Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer".

Ranjan Kumar Acharyya, Rohan Kalyan Rej, Biao Hu

|Nov 25, 2024
Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degrader of Estrogen Receptor α (ERα).

Rohan Kalyan Rej, Biao Hu, Zhixiang Chen

Pageof 2

Frequent Collaborators

7 joint publications

Shaomeng Wang

5 joint publications

Rohan Kalyan Rej

4 joint publications

WenXue Wu

4 joint publications

Duxin Sun